Literature DB >> 11566359

Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.

K J Bailey-Dell1, B Hassel, L A Doyle, D D Ross.   

Abstract

The breast cancer resistance protein (BCRP) gene, formally known as ATP-binding cassette transporter G2 (ABCG2) gene, encodes an ABC half transporter that causes resistance to certain cancer chemotherapeutic drugs when transfected and expressed in drug sensitive cancer cells. Here we report the organization of the BCRP gene, and the initial characterization of the BCRP promoter. We identified the genomic sequence of BCRP and its promoter by screening a human genomic lambda phage library, as well as a BAC library, and by searching the human genome database. The BCRP gene spans over 66 kb and consists of 16 exons and 15 introns. The exons range in size from 60 to 532 bp. The translational start site is found in the second exon. The first exon contains the majority of the 5' UTR. Promoter activity was characterized by a luciferase reporter assay using transient transfection of the human breast cancer cell line MCF7, and the human choriocarcinoma cell lines JAR, BeWo and JEG-3, which we find to have high endogenous expression of BCRP. The BCRP gene is transcribed by a TATA-less promoter with several putative Sp1 sites, which are downstream from a putative CpG island. The sequence 312 bp directly upstream from the BCRP transcriptional start site conferred basal promoter activity. The 5' region upstream of the basal promoter is characterized by both positive and negative regulatory domains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566359     DOI: 10.1016/s0167-4781(01)00270-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  55 in total

Review 1.  Pharmacogenomics of the human ABC transporter ABCG2: from functional evaluation to drug molecular design.

Authors:  Toshihisa Ishikawa; Ai Tamura; Hikaru Saito; Kanako Wakabayashi; Hiroshi Nakagawa
Journal:  Naturwissenschaften       Date:  2005-10

Review 2.  ATP-binding cassette, subfamily G (ABCG family).

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Pflugers Arch       Date:  2006-09-16       Impact factor: 3.657

3.  Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype.

Authors:  Wook-Jin Yang; Min-Ji Song; Eun Young Park; Jong-Joo Lee; Joo-Hong Park; Keunhee Park; Jong Hoon Park; Hyoung-Pyo Kim
Journal:  Mol Cells       Date:  2013-08-29       Impact factor: 5.034

4.  ABCG2 expression, function, and promoter methylation in human multiple myeloma.

Authors:  Joel G Turner; Jana L Gump; Chunchun Zhang; James M Cook; Douglas Marchion; Lori Hazlehurst; Pamela Munster; Michael J Schell; William S Dalton; Daniel M Sullivan
Journal:  Blood       Date:  2006-08-17       Impact factor: 22.113

5.  Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts.

Authors:  Naveen K Neradugomma; Michael Z Liao; Qingcheng Mao
Journal:  Mol Pharmacol       Date:  2016-12-14       Impact factor: 4.436

Review 6.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

7.  Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.

Authors:  Eran E Bram; Michal Stark; Shachar Raz; Yehuda G Assaraf
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

8.  Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment.

Authors:  Satoru Yasuda; Masaki Kobayashi; Shirou Itagaki; Takeshi Hirano; Ken Iseki
Journal:  Mol Biol Rep       Date:  2008-11-08       Impact factor: 2.316

Review 9.  PharmGKB summary: very important pharmacogene information for ABCG2.

Authors:  Alison E Fohner; Deanna J Brackman; Kathleen M Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2017-11       Impact factor: 2.089

10.  Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha.

Authors:  J van der Heijden; M C de Jong; B A C Dijkmans; W F Lems; R Oerlemans; I Kathmann; C G Schalkwijk; G L Scheffer; R J Scheper; G Jansen
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.